摘要
【目的】探讨白介素-17A(IL-17A)对HepG2细胞凋亡的影响及作用机制。【方法】培养正常肝细胞(L-02)及肝癌细胞(Huh7、HepG2和PLC/PRF/5),荧光实时定量PCR(qRT-PCR)、Westernblot测定其细胞IL-17A表达。然后取HepG2细胞,予重组IL-17A(rIL-17A)和(或)髓细胞白血病因子-1(Mel-1)siRNA处理,流式细胞术分析细胞凋亡率;qRT-PCR、Westernblot检测Mcl-1表达。【结果】相对于L-02细胞,Huh7、HePG2和PLC/PRF/5细胞IL-17AmRNA与蛋白水平明显增加,以HepG2细胞最高(P〈0.01)。rIL-17A使HepG2细胞凋亡减少(Pd0.01),MCl-1表达上调(P〈0.01)。MCl-1siRNA预处理则逆转rIL广17A对HepG2细胞凋亡的抑制作用(Pd0.05)。【结论】肝癌细胞IL-17A呈高表达,IL-17A通过上调MCl-1表达发挥抗HepG2细胞凋亡作用。
[Objective]To explore the effects of interleukin-17A (IL-17A) on apoptosis of HepG2 cell and investigate the novel mechanism. [Methods]Quantitative real-time PCR (qRT-PCR) and Western blot were used to detect IL-17A expression in normal hepatocytes (L-02) and hepatic cancer cell lines (HuhT, HepG2 and PLC/PRF/5). Subsequently, HepG2 ceils were selected and treated with recombinant IL-17A (rlL-17A) and/or myeloid cell leukemia-1 (Mcl-1) siRNA. Apoptotic rate was analyzed by flow cytometry. The expres- sion of Mcl-1 was measured by qRT-PCR and Western Blot. [Results] Compared to those in L-02 cells, the mRNA and protein levels of IL-17A were significantly increased in Huh7, HepG2 and PLC/PRF/5 cells, and HepG2 cells had the highest expression ( P 〈0.01). Administration of rIL-17A reduced apoptotic rate and in- creased Mcl-1 expression in HepG2 cells (P 〈0.01). However, siRNA-mediated knockdown of Mcl-1 re- versed the inhibitory effect of rlL-17A on HepG2 cell apoptosis ( P 〈0.05).[Conclusion]IL-17A is highly ex- pressed in hepatic cancer cells. IL-17A reduces HepG2 cell apoptosis by upregulating Mcl-1 expression.
作者
尹文君
李绵利
王秋平
姜孝新
YIN Wen-jun;LIMian-li;WANG Qiu-ping(Department of Clinical Laboratory,the First Affiliated Hospital to University of South China,Hengyang,Hunan 421001,China)
出处
《医学临床研究》
CAS
2018年第10期1883-1885,共3页
Journal of Clinical Research
基金
湖南省自然科学基金资助项目(编号:2018JJ3166)